ERXL-201

N/A

Report date: 2023/08/01 18:01:59
NMEFirst In Class

Base Information

Drug NameERXL-201
Drug Alias NameERXL-201
ClassificationSmall molecules
Mechanisms of ActionMacrophages modulators
TargetsUpdating
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEndurx Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAtherosclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A